Honored to be a part of this collaborative study that demonstrated an AI CTM allows efficient and reliable screening of lung CA patients for clinical trials in Australia, with 96% accuracy in exclusion & 92% performance in assessing overall potential eligibility. @IBMWatsonhttps://twitter.com/gpurcelljackson/status/1258124280010866690 …
-
-
Thank you
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.
